CA2220103C - Compositions a base d'amoxycilline et d'acide clavulanique - Google Patents

Compositions a base d'amoxycilline et d'acide clavulanique Download PDF

Info

Publication number
CA2220103C
CA2220103C CA002220103A CA2220103A CA2220103C CA 2220103 C CA2220103 C CA 2220103C CA 002220103 A CA002220103 A CA 002220103A CA 2220103 A CA2220103 A CA 2220103A CA 2220103 C CA2220103 C CA 2220103C
Authority
CA
Canada
Prior art keywords
amoxycillin
day
clavulanic acid
potassium clavulanate
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002220103A
Other languages
English (en)
Other versions
CA2220103A1 (fr
Inventor
Richard Peregrine Bax
Mike Gale Ramsey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
GlaxoSmithKline LLC
Original Assignee
SmithKline Beecham Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9508989.2A external-priority patent/GB9508989D0/en
Priority claimed from GBGB9523655.0A external-priority patent/GB9523655D0/en
Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Priority claimed from PCT/EP1996/001881 external-priority patent/WO1996034605A1/fr
Publication of CA2220103A1 publication Critical patent/CA2220103A1/fr
Application granted granted Critical
Publication of CA2220103C publication Critical patent/CA2220103C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
CA002220103A 1995-05-03 1996-05-02 Compositions a base d'amoxycilline et d'acide clavulanique Expired - Lifetime CA2220103C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9508989.2 1995-05-03
GBGB9508989.2A GB9508989D0 (en) 1995-05-03 1995-05-03 Pharmaceutical formulations
GBGB9523655.0A GB9523655D0 (en) 1995-11-18 1995-11-18 Method of treatment
GB9523655.0 1995-11-18
PCT/EP1996/001881 WO1996034605A1 (fr) 1995-05-03 1996-05-02 Compositions a base d'amoxycilline et d'acide clavulanique

Publications (2)

Publication Number Publication Date
CA2220103A1 CA2220103A1 (fr) 1996-11-07
CA2220103C true CA2220103C (fr) 2006-06-20

Family

ID=37392932

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002220103A Expired - Lifetime CA2220103C (fr) 1995-05-03 1996-05-02 Compositions a base d'amoxycilline et d'acide clavulanique

Country Status (1)

Country Link
CA (1) CA2220103C (fr)

Also Published As

Publication number Publication date
CA2220103A1 (fr) 1996-11-07

Similar Documents

Publication Publication Date Title
AU712269C (en) Composition comprising amoxycillin and clavulanic acid
AU722657B2 (en) Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia
EP0862431B1 (fr) Utilisaton d'une preparation pharmaceutique pediatrique contenant de l'amoxicilline et du clavulanate
US20020099044A1 (en) Composition comprising amoxycillin and clavulanic acid
ZA200510098B (en) Pharmaceutical formulations comprising amoxicillin and clavulanate
CA2220103C (fr) Compositions a base d'amoxycilline et d'acide clavulanique
EP1491195A1 (fr) Formulations pharmaceutiques comprenant de l'amoxicilline et du clavulanate
MXPA99001807A (en) Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia
CZ11407U1 (cs) Farmaceutický prostředek uzpůsobený pro pediatrické podávání

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20160502